[1]
Furneri, G. et al. 2016. [Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]. Farmeconomia. Health economics and therapeutic pathways. 17, 1 (Mar. 2016), 29–39. DOI:https://doi.org/10.7175/fe.v17i1.1237.